3rd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$160,323
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Health Savings Accounts; Primary Care Enhancement Act

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; SENATE; Government Accountability Office (GAO)

Health Issues HCR

Medicare Physician Payment Reform; Physician Workforce

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); White House Office; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO)

Budget/Appropriations BUD

National Health Service Corps; Community Health Centers; Health Resource & Services Administration

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC)

Insurance INS

Professional Liability Insurance; Health Insurance

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE

Medical/Disease Research/Clinical Labs MED

NIH; FDA

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: White House Office; Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); White House Office; SENATE

Medicare/Medicaid MMM

Graduate Medical Education; Resident Physician Shortage Act; Independent Payment Advisory Board (IPAB)

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: White House Office; Office of Management & Budget (OMB); Government Accountability Office (GAO); SENATE; HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC)

Education EDU

Teaching Health Center Graduate Medical Education; National Health Service Corps; Foreign Medical School Accountability Fairness Act; Single Accreditation

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); White House Office; Executive Office of the President (EOP); Government Accountability Office (GAO); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA)

Torts TOR

Medical Liability Reform; Protecting Access to Care Act; Good Samaritan Health Professionals Act

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Executive Office of the President (EOP); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.